Zacks Research Has Optimistic Outlook of JNJ Q2 Earnings
Johnson & Johnson (NYSE:JNJ – Free Report) – Equities researchers at Zacks Research lifted their Q2 2025 earnings estimates for Johnson & Johnson in a note issued to investors on Wednesday, February 12th. Zacks Research analyst K. Shah now anticipates that the company will earn $2.69 per share for the quarter, up from their previous […]
